Dicot Pharma AB (STO:DICOT)

Dicot Pharma AB Income Statement

Financials in millions SEK. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Other Operating Expenses	0.19	0	0.19	0.2	0.17	0.11
Total Operating Expenses	0.19	0	0.19	0.2	0.17	0.11
Operating Income	-73.8	-82.4	-59.25	-45.01	-31.72	-27.17
Interest Income	-	2.2	1.57	0.91	0	0
Interest Expense	-	0	-0.01	-0.07	-0.03	-0
Other Non-Operating Income (Expense)	-	-	-	-	-	-0
Total Non-Operating Income (Expense)	-	2.2	1.56	0.85	-0.03	-0.01
Pretax Income	-73.8	-80.2	-57.7	-44.16	-31.76	-27.17
Net Income	-73.8	-80.2	-57.7	-44.16	-31.76	-27.17
Net Income to Common	-72	-80.2	-57.7	-44.16	-31.76	-27.17
Net Income Growth	-	-	-	-	-	-
Shares Outstanding (Basic)	1,998	1,947	1,091	530	120	52
Shares Outstanding (Diluted)	2,013	1,955	1,343	675	121	52
Shares Change (YoY)	37.33%	45.56%	99.09%	456.00%	133.32%	81.92%
EPS (Basic)	-0.04	-0.04	-0.05	-0.26	-0.26	-0.52
EPS (Diluted)	-0.04	-0.04	-0.05	-0.26	-0.26	-0.52
EPS Growth	-	-	-	-	-	-
Free Cash Flow	-78.45	-85.85	-58.87	-45.23	-29.71	-25.87
Free Cash Flow Growth	-	-	-	-	-	-
Free Cash Flow Per Share	-0.04	-0.04	-0.04	-0.07	-0.24	-0.50
EBITDA	-73.8	-82.4	-59.25	-45	-31.72	-27.16
EBIT	-73.8	-82.4	-59.25	-45.01	-31.72	-27.17

Data Source: Fiscal.ai Last updated: Apr 30, 2026

Financial data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 22, 2026

Data Sources Report a data error